ALLEGRA Drug Patent Profile
✉ Email this page to a colleague
When do Allegra patents expire, and when can generic versions of Allegra launch?
Allegra is a drug marketed by Chattem Sanofi and is included in five NDAs.
The generic ingredient in ALLEGRA is fexofenadine hydrochloride; pseudoephedrine hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride; pseudoephedrine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Allegra
A generic version of ALLEGRA was approved as fexofenadine hydrochloride; pseudoephedrine hydrochloride by DR REDDYS LABS LTD on June 22nd, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALLEGRA?
- What are the global sales for ALLEGRA?
- What is Average Wholesale Price for ALLEGRA?
Summary for ALLEGRA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 224 |
Clinical Trials: | 35 |
Patent Applications: | 4,386 |
Drug Sales Revenues: | Drug sales revenues for ALLEGRA |
DailyMed Link: | ALLEGRA at DailyMed |
Recent Clinical Trials for ALLEGRA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Food and Drug Administration (FDA) | Early Phase 1 |
University of California, San Francisco | Early Phase 1 |
University of Alabama at Birmingham | Phase 2 |
US Patents and Regulatory Information for ALLEGRA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chattem Sanofi | ALLEGRA | fexofenadine hydrochloride | CAPSULE;ORAL | 020625-001 | Jul 25, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chattem Sanofi | ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION | fexofenadine hydrochloride; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020786-002 | Jan 24, 2011 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chattem Sanofi | ALLEGRA ALLERGY | fexofenadine hydrochloride | TABLET;ORAL | 020872-010 | Jan 24, 2011 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ALLEGRA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chattem Sanofi | ALLEGRA | fexofenadine hydrochloride | SUSPENSION;ORAL | 021963-001 | Oct 16, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Chattem Sanofi | ALLEGRA | fexofenadine hydrochloride | SUSPENSION;ORAL | 021963-001 | Oct 16, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Chattem Sanofi | ALLEGRA | fexofenadine hydrochloride | SUSPENSION;ORAL | 021963-001 | Oct 16, 2006 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ALLEGRA
See the table below for patents covering ALLEGRA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2254506 | DERIVES DE LA PIPERIDINE ET METHODE DE PREPARATION (PIPERIDINE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION) | ⤷ Sign Up |
Germany | 69433346 | ⤷ Sign Up | |
Norway | 964859 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |